The Effect of All Extremity High Intensity Interval Training on Athero‑Protective Factors and Endothelial Function in Overweight and Obese Women

Volga Hovsepian, Sayad M Marandi, Fahimeh Esfarjani, Reihaneh Zavar, Masoumeh Sadeghi

Abstract


Context: Obesity is associated with endothelial dysfunction and cardiovascular diseases. Adiponectin and fibroblast growth factor 21 (FGF21) as hormones are highly contributive in cardiovascular system, while they are disrupted through obesity. Weight‑bearing high intensity interval training (HIIT) as an effective procedure in preventing obesity‑related complications in adults with obesity may be limited due to the subjects’ muscular weakness and complications interfering walking. Aims: The purpose of this study was to assess the effectiveness of non‑weight bearing all extremity HIIT (all ex. HIIT) on FGF21, adiponectin, nitric oxide (NO), and flow mediated dilation (FMD) in overweight and obese women. Methods: Thirty healthy overweight and obese sedentary university female students within 20.53 ± 1.50 age range and BMI ≥27 kg.m‑2 were assigned in two experimental and control groups. All ex. HIIT consisted of 4 × 4 min at 85–90% max HR with an interspersed with 3 × 3 min recovery per round at 70% max HR by upper and lower ergometers in a simultaneous manner on 10 weeks of four sessions of 40 min each. FGF21, adiponectin, NO, FMD, weight, waist and maximal oxygen uptake (VO2max) were measured in pre and post‑tests. Paired sample t‑test and analysis of covariance are applied for statistical analysis. Results: Results indicated a significant increase in adiponectin (P ≤ 0.01) and FMD (P ≤ 0.001), while there existed no changes in FGF21 at (P ≥ 0.10) and NO (P ≥ 0.84). The weight and waist decreased at (P ≤ 0.001), and the VO2max increased at (P ≤ 0.001). Conclusions: All ex. HIIT may be a safe alternative for overweigh and obese women who have complications with weight‑bearing exercises, and may increase adiponectin, and improve the FMD, aerobic fitness, and body composition.

Keywords


Adiponectin; atherosclerosis; fibroblast growth factor 21; high intensity interval training

Full Text:

PDF

References


Khosravi ZS, Kafeshani M, Tavasoli P, Zadeh AH, Entezari MH.

Effect of vitamin D supplementation on weight loss, glycemic

indices, and lipid profile in obese and overweight women:

A clinical trial study. Int J Prev Med 2018;9.

Romacho T, Elsen M, Röhrborn D, Eckel J. Adipose tissue and

its role in organ crosstalk. Acta physiologica 2014;210:733‑53.

Scherer PE. Adipose tissue: From lipid storage compartment to

endocrine organ. Diabetes 2006;55:1537‑45.

Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and

cardiovascular disease: State of the art? Am J Physiol Heart Circ

Physiol 2007;292:H1655‑H63.

Kliewer SA, Mangelsdorf DJ. Fibroblast growth factor 21: From

pharmacology to physiology. Am J Clin Nutr 2010;91:254S‑7S.

Geng L, Liao B, Jin L, Huang Z, Triggle CR, Ding H, et al.

Exercise alleviates obesity‑induced metabolic dysfunction

via enhancing FGF21 sensitivity in adipose tissues. Cell Rep

;26:2738‑52. e4.

Iwabu M, Okada‑Iwabu M, Yamauchi T, Kadowaki T.

Adiponectin/AdipoR research and its implications for

lifestyle‑related diseases. Front Cardiovasc Med 2019;6:116.

Katsiki N, Mantzoros C. Fibroblast growth factor 21: A role in

cardiometabolic disorders and cardiovascular risk prediction?

Metabolism 2019;93:iii‑v.

Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The

adipocyte‑secreted protein Acrp30 enhances hepatic insulin

action. Nat Med 2001;7:947.

Kokkinos J, Tang S, Rye KA, Ong KL. The role of fibroblast

growth factor 21 in atherosclerosis. Atherosclerosis

;257:259‑65.

Lin Z, Pan X, Wu F, Ye D, Zhang Y, Wang Y, et al. Fibroblast

growth factor 21 prevents atherosclerosis by suppression of

hepatic sterol regulatory element‑binding protein‑2 and induction

of adiponectin in mice. Circulation 2015;131:1861‑31.

Ouchi N, Walsh K. Adiponectin as an anti‑inflammatory factor.

Clinica Chimica Acta 2007;380:24‑30.

Hui X, Feng T, Liu Q, Gao Y, Xu A. The FGF21–adiponectin

axis in controlling energy and vascular homeostasis. J Mol Cell

Biol 2016;8:110‑9.

Yang W, Liu L, Wei Y, Fang C, Zhou F, Chen J, et al. Exercise

ameliorates the FGF21–adiponectin axis impairment in

diet‑induced obese mice. Endocr Connect 2019;8:596‑604.

Mikołajczak A, Oświęcimska J, Świętochowska E,

Roczniak W, Ziora K. Serum FGF21 in girls with anorexia

nervosa–comparison to normal weight and obese female

adolescents. Neuro Endocrinol Lett 2017;38:173‑81.

Montero D, Walther G, Benamo E, Perez‑Martin A, Vinet A.

Effects of exercise training on arterial function in type 2 diabetes

mellitus. Sports Med 2013;43:1191‑9.

Hollekim‑Strand SM, Bjørgaas MR, Albrektsen G, Tjønna AE,

Wisløff U, Ingul CB. High‑intensity interval exercise effectively

improves cardiac function in patients with type 2 diabetes

mellitus and diastolic dysfunction: A randomized controlled trial.

J Am Coll Cardiol 2014;64:1758‑60.

Molmen‑Hansen HE, Stolen T, Tjonna AE, Aamot IL,

Ekeberg IS, Tyldum GA, et al. Aerobic interval training reduces

blood pressure and improves myocardial function in hypertensive

patients. Eur J Prev Cardiol 2012;19:151‑60.

Ramos JS, Dalleck LC, Tjonna AE, Beetham KS,

Coombes JS. The impact of high‑intensity interval training

versus moderate‑intensity continuous training on vascular

function: A systematic review and meta‑analysis. Sports Med

;45:679‑92.

Hills A, Hennig E, Byrne N, Steele J. The biomechanics of

adiposity–structural and functional limitations of obesity and

implications for movement. Obes Rev 2002;3:35‑43.

Kim HK, Hwang Cl, Yoo JK, Hwang MH, Handberg EM,

Petersen JW, et al. All‑extremity exercise training improves

arterial stiffness in older adults. Med Sci Sports Exerc

;49:1404‑11.

Golding L. YMCA Fitness Testing and Assessment Manual.

Champaign, IL: Human Kinetics; 2000.

Wilbur J, Naftzger‑Kang L, Miller AM, Chandler P,

Montgomery A. Women’s occupations, energy expenditure, and

cardiovascular risk factors. J Women’s Health 1999;8:377‑87.

Hashemi SM, Mokhtari SM, Sadeghi M, Foroozan R, Safari M.

Effect of vitamin D therapy on endothelial function in ischemic

heart disease female patients with vitamin D deficiency or

insufficiency: A primary report. ARYA Atheroscler 2015;11:54‑9.

Ahmadi A, Akbarzadeh M, Mohammadi F, Akbari M, Jafari B,

Tolide‑Ie HR. Anthropometric characteristics and dietary pattern

of women with polycystic ovary syndrome. Indian J Endocrinol

Metabol 2013;17:672‑6.

Hwang CL, Yoo JK, Kim HK, Hwang MH, Handberg EM,

Petersen JW, et al. Novel all‑extremity high‑intensity interval

training improves aerobic fitness, cardiac function and insulin

resistance in healthy older adults. Exp Gerontol 2016;82:112‑9.

Madsen SM, Thorup AC, Overgaard K, Bjerre M, Jeppesen PB.

Functional and structural vascular adaptations following 8 weeks

of low volume high intensity interval training in lower leg of

type 2 diabetes patients and individuals at high risk of metabolic

syndrome. Arch Physiol Biochem 2015;121:178‑86.

Yang SJ, Hong HC, Choi HY, Yoo HJ, Cho GJ, Hwang TG,

et al. Effects of a three‐month combined exercise programme

on fibroblast growth factor 21 and fetuin‐A levels and arterial

stiffness in obese women. Clin Endocrinol 2011;75:464‑9.

Cuevas‑Ramos D, Almeda‑Valdés P, Meza‑Arana CE,

Brito‑Córdova G, Gómez‑Pérez FJ, Mehta R, et al. Exercise

increases serum fibroblast growth factor 21 (FGF21) levels.

PLoS One 2012;7:e38022.

Racil G, Ounis OB, Hammouda O, Kallel A, Zouhal H,

Chamari K, et al. Effects of high vs. moderate exercise intensity

during interval training on lipids and adiponectin levels in obese

young females. Eur J Appl Physiol 2013;113:2531‑40.

Kim ES, Im JA, Kim KC, Park JH, Suh SH, Kang ES, et al.

Improved insulin sensitivity and adiponectin level after exercise

training in obese Korean youth. Obesity 2007;15:3023‑30.

Lim S, Choi SH, Jeong IK, Kim JH, Moon MK, Park KS,

et al. Insulin‑sensitizing effects of exercise on adiponectin

and retinol‑binding protein‑4 concentrations in young and

middle‑aged women. J Clin Endocrinol Metab 2008;93:2263‑8.

Corbi G, Polito R, Monaco ML, Cacciatore F, Scioli M,

Ferrara N, et al. Adiponectin expression and genotypes in Italian

people with severe obesity undergone a hypocaloric diet and

physical exercise program. Nutrients 2019;11:2195.

Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE,

Slentz CA, et al. Adiponectin is not altered with exercise training

despite enhanced insulin action. Am J Physiol Endocrinol Metab

;283:E861‑E5.

Hwang CL, Lim J, Yoo JK, Kim HK, Hwang MH, Handberg EM,

et al. Effect of all‑extremity high‑intensity interval training vs.

moderate‑intensity continuous training on aerobic fitness in

middle‑aged and older adults with type 2 diabetes: A randomize controlled trial. Exp Gerontol 2019;116:46‑53.

Sawyer BJ, Tucker WJ, Bhammar DM, Ryder JR, Sweazea KL,

Gaesser GA. Effects of high‑intensity interval training and

moderate‑intensity continuous training on endothelial function

and cardiometabolic risk markers in obese adults. J Appl Physiol

;121:279‑88.

Klonizakis M, Moss J, Gilbert S, Broom D, Foster J, Tew GA.

Low‑volume high‑intensity interval training rapidly improves

cardiopulmonary function in postmenopausal women. Menopause

;21:1099‑105.

Green DJ, Maiorana A, O’driscoll G, Taylor R. Effect of exercise

training on endothelium-derived nitric oxide function in humans.

J Physiol 2004;561:1‑25.

Gaitanos GC, Williams C, Boobis LH, Brooks S. Human muscle

metabolism during intermittent maximal exercise. J Appl Physiol

;75:712‑9.

Carter JG, Brooks KA, Sparks JR, editors. Comparison of

the YMCA cycle sub‑maximal VO2 max test to a treadmill

VO2 max test. Int J Exerc Sci 2011;5:40.